Structures by: Silva L. E.
Total: 42
N-(5,7-Dibromo-8-quinolyl)-3,5-difluorobenzenesulfonamide
C21H10Br2F4N2O4S2
Acta Crystallographica Section E (2006) 62, 7 o2630-o2631
a=9.7580(10)Å b=24.091(2)Å c=9.8510(10)Å
α=90° β=99.560(10)° γ=90°
Aquabis[N-(5,7-dibromoquinolin-8-yl)-4-methylbenzenesulfonamidato- κ^2^N,N]zinc(II)
C32H24Br4N4O5S2Zn
Acta Crystallographica Section E (2006) 62, 6 m1258-m1259
a=15.8969(9)Å b=15.8969Å c=12.1289(9)Å
α=90.00° β=90.00° γ=120.00°
Bis[4-fluoro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II) hemihydrate
C30H20F2N4O4S2Zn,0.5H2O
Acta Crystallographica Section E (2006) 62, 7 m1719-m1721
a=23.4010(10)Å b=16.8430(10)Å c=17.1860(10)Å
α=90.00° β=123.7100(10)° γ=90.00°
Bis[4-fluoro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]copper(II) dichloromethane hemisolvate
C30H20CuF2N4O4S2,0.5CH2Cl2
Acta Crystallographica Section E (2006) 62, 7 m1606-m1608
a=32.228(3)Å b=10.4050(10)Å c=23.817(2)Å
α=90.00° β=130.700(10)° γ=90.00°
6-Nitroquinolin-2(1H)-one
C9H6N2O3
Acta Crystallographica Section E (2005) 61, 9 o2992-o2993
a=11.470(2)Å b=4.8880(6)Å c=15.065(2)Å
α=90.00° β=99.530(10)° γ=90.00°
2,2-Dimethyl-5-[(1,2,4-triazin-3-ylamino)methylene]-1,3-dioxane-4,6-dione
C10H10N4O4
Acta Crystallographica Section E (2005) 61, 9 o2873-o2874
a=6.379(5)Å b=18.239(5)Å c=10.101(5)Å
α=90.00° β=107.331(5)° γ=90.00°
5-{[4-(4-Bromophenyl)thiazol-2-yl]aminomethylene}-2,2-dimethyl-1,3- dioxane-4,6-dione
C16H13BrN2O4S
Acta Crystallographica Section E (2006) 62, 5 o1722-o1723
a=7.8262(6)Å b=9.4869(7)Å c=11.8847(7)Å
α=70.969(5)° β=79.213(6)° γ=77.059(6)°
5-[(4-Methoxyphenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C14H15NO5
Acta Crystallographica Section E (2005) 61, 12 o4121-o4122
a=13.007(3)Å b=7.1317(14)Å c=14.743(3)Å
α=90.00° β=102.14(3)° γ=90.00°
5-[(2-Bromophenylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C13H12BrNO4
Acta Crystallographica Section E (2005) 61, 12 o4252-o4253
a=6.960(5)Å b=9.298(5)Å c=10.424(5)Å
α=95.570(5)° β=101.043(5)° γ=99.508(5)°
5-[(4-Methylthiazol-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C11H12N2O4S
Acta Crystallographica Section E (2006) 62, 3 o1163-o1164
a=5.6384(6)Å b=18.562(4)Å c=11.920(2)Å
α=90.00° β=103.140(10)° γ=90.00°
5-(5-Ethyl-1,3,4-thiadiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane- 4,6-dione
C11H13N3O4S
Acta Crystallographica Section E (2006) 62, 4 o1520-o1521
a=10.733(2)Å b=9.8420(10)Å c=24.650(2)Å
α=90.00° β=90.00° γ=90.00°
Bis[4-n-propyl-N-(8-quinolyl)benzenesulfonamidato-k^2^N,N']zinc(II) dimethylformamide solvate
C36H34N4O4S2Zn,C3H7NO
Acta Crystallographica Section E (2006) 62, 5 m999-m1001
a=15.385(2)Å b=16.928(2)Å c=16.170(2)Å
α=90.00° β=115.300(10)° γ=90.00°
Quinolin-8-yl 2,5-dichlorobenzenesulfonate
C15H9Cl2NO3S
Acta Crystallographica Section E (2006) 62, 6 o2104-o2105
a=7.8420(10)Å b=25.536(3)Å c=7.6420(10)Å
α=90.00° β=107.870(10)° γ=90.00°
C9H10N4O4,H2O
C9H10N4O4,H2O
Acta Crystallographica Section E (2005) 61, 8 o2642-o2643
a=18.012(5)Å b=5.356(5)Å c=12.937(5)Å
α=90.00° β=108.786(5)° γ=90.00°
4,5-Dibromo-N-(8-quinolyl)thiophene-2-sulfonamide
C13H8Br2N2O2S2
Acta Crystallographica Section E (2006) 62, 1 o309-o310
a=28.318(2)Å b=7.0471(5)Å c=15.0940(10)Å
α=90.00° β=90.00° γ=90.00°
2,2-Dimethyl-5-[(4-p-tolylthiazol-2-ylamino)methylene]-1,3- dioxane-4,6-dione
C17H16N2O4S
Acta Crystallographica Section E (2006) 62, 8 o3215-o3216
a=7.7951(8)Å b=9.5345(9)Å c=11.8050(10)Å
α=71.034(9)° β=78.564(9)° γ=76.671(9)°
Bis[N-(5,7-dibromoquinolin-8-yl)-3,5-bis(trifluoromethyl)benzenesulfonamidato- κ^2^N,N]zinc(II)
C34H14Br4F12N4O4S2Zn
Acta Crystallographica Section E (2006) 62, 8 m1901-m1903
a=11.7057(6)Å b=12.4768(6)Å c=14.0759(7)Å
α=90.091(4)° β=100.293(4)° γ=100.519(4)°
Aquabis[4-nitro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II)
C30H22N6O9S2Zn
Acta Crystallographica Section E (2006) 62, 8 m1773-m1775
a=31.407(6)Å b=10.1200(10)Å c=10.3420(10)Å
α=90.00° β=106.94(2)° γ=90.00°
5-[(6-Methylpyridin-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C13H14N2O4
Acta Crystallographica Section E (2006) 62, 8 o3477-o3478
a=17.1010(10)Å b=7.3540(10)Å c=21.375(2)Å
α=90.00° β=91.868(9)° γ=90.00°
5,7-Dibromo-N-tosylquinolin-8-amine
C16H12Br2N2O2S
Acta Crystallographica Section E (2005) 61, 10 o3435-o3436
a=4.9390(10)Å b=16.595(3)Å c=20.254(4)Å
α=90.00° β=90.00° γ=90.00°
5-(5-Bromothiazol-2-ylaminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione ?
C10H9BrN2O4S
Acta Crystallographica Section E (2006) 62, 3 o1062-o1063
a=5.408(5)Å b=18.013(5)Å c=13.114(5)Å
α=90.00° β=100.717(5)° γ=90.00°
2-(1,3-Benzothiazol-2-yl)quinolin-8-ol
C16H10N2OS
Acta Crystallographica Section E (2006) 62, 3 o880-o881
a=12.182(2)Å b=8.0602(8)Å c=26.061(3)Å
α=90.00° β=91.530(10)° γ=90.00°
Bis[2,4,6-triisopropyl-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]zinc(II)
C48H58N4O4S2Zn
Acta Crystallographica Section E (2006) 62, 3 m516-m517
a=9.9732(6)Å b=14.3281(8)Å c=17.0425(8)Å
α=71.723(5)° β=79.277(4)° γ=69.875(5)°
Bis[4-nitro-N-(quinolin-8-yl)benzenesulfonamidato-κ^2^N,N]copper(II)
C30H20CuN6O8S2
Acta Crystallographica Section E (2006) 62, 3 m518-m519
a=14.101(2)Å b=16.823(2)Å c=13.172(2)Å
α=90.00° β=102.350(10)° γ=90.00°
5-(Aminomethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione
C7H9NO4
Acta Crystallographica Section E (2006) 62, 9 o3866-o3867
a=9.8300(10)Å b=9.6090(10)Å c=16.819(2)Å
α=90.00° β=90.950(10)° γ=90.00°
2-Aminoquinolin-8-yl 2,4,6-triisopropylbenzenesulfonate
C24H30N2O3S
Acta Crystallographica Section E (2007) 63, 1 o409-o411
a=40.435(3)Å b=7.0362(4)Å c=17.212(2)Å
α=90.00° β=101.754(9)° γ=90.00°
2-Aminoquinolin-8-yl 4-fluorobenzenesulfonate
C15H11FN2O3S
Acta Crystallographica Section E (2007) 63, 1 o407-o408
a=7.8513(9)Å b=8.0764(9)Å c=11.6800(10)Å
α=89.482(9)° β=79.070(9)° γ=77.738(9)°
2-Aminoquinolin-8-yl 4-p-toluenesulfonate
C16H14N2O3S
Acta Crystallographica Section E (2007) 63, 1 o72-o74
a=8.3340(10)Å b=8.6360(10)Å c=11.8050(10)Å
α=96.350(10)° β=110.230(10)° γ=106.900(10)°
<i>N</i>-(4-Methoxybenzyl)quinoline-8-sulfonamide
C17H16N2O3S
Acta Crystallographica Section E (2007) 63, 7 o3059-o3059
a=7.2730(10)Å b=9.1460(10)Å c=22.975(3)Å
α=90.00° β=90.00° γ=90.00°
5-[(8-Hydroxyquinolin-2-ylamino)methylene]-2,2-dimethyl-1,3-dioxane-4,6-dione
C16H14N2O5
Acta Crystallographica Section E (2007) 63, 8 o3439-o3439
a=7.445(2)Å b=8.440(2)Å c=12.906(3)Å
α=77.310(10)° β=86.81(2)° γ=73.150(10)°
<i>N</i>-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro- 1<i>H</i>-pyrazol-4-yl)-4-methylbenzenesulfonamide
C18H19N3O3S
Acta Crystallographica Section E (2008) 64, 1 o52-o52
a=9.2020(10)Å b=9.8920(10)Å c=10.0670(10)Å
α=103.688(9)° β=90.360(9)° γ=104.300(9)°
2-Aminoquinolin-8-yl 3,5-difluorobenzenesulfonate
C15H10F2N2O3S
Acta Crystallographica Section E (2007) 63, 2 o829-o830
a=7.7926(7)Å b=9.2530(10)Å c=9.7950(10)Å
α=90.233(9)° β=96.787(8)° γ=92.516(8)°
8-(Piperidin-1-ylsulfonyl)quinoline
C14H16N2O2S
Acta Crystallographica Section E (2007) 63, 4 o1638-o1639
a=7.2682(7)Å b=14.319(2)Å c=14.411(2)Å
α=111.31(2)° β=101.490(10)° γ=100.710(10)°
4-n-Propyl-N-(8-quinolyl)benzenesulfonamide
C18H18N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3606-o3607
a=6.7242(8)Å b=14.0310(10)Å c=17.5130(10)Å
α=90.00° β=90.891(9)° γ=90.00°
4-Bromo-N-8-quinolylbenzenesulfonamide
C15H11BrN2O2S
Acta Crystallographica Section E (2007) 63, 4 o1648-o1649
a=6.7800(10)Å b=14.253(3)Å c=15.232(4)Å
α=90.00° β=100.43(2)° γ=90.00°
4-Bromo-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>- pyrazol-4-yl)benzenesulfonamide
C17H16BrN3O3S
Acta Crystallographica Section E (2007) 63, 12 o4820-o4820
a=7.9790(10)Å b=14.099(2)Å c=15.685(3)Å
α=90.00° β=90.00° γ=90.00°
2,5-Dichloro<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>- pyrazol-4-yl)benzenesulfonamide
C17H15Cl2N3O3S
Acta Crystallographica Section E (2007) 63, 12 o4821-o4821
a=8.009(2)Å b=10.697(3)Å c=11.201(5)Å
α=102.17(3)° β=92.23(2)° γ=108.69(3)°
2-Aminoquinolin-4-yl 2,4,6-triisopropylbenzenesulfonate
C24H30N2O3S
Acta Crystallographica Section E (2006) 62, 12 o5421-o5422
a=9.4310(10)Å b=11.015(2)Å c=12.312(2)Å
α=77.610(10)° β=80.790(10)° γ=69.110(10)°
N-Benzylquinoline-8-sulfonamide
C16H14N2O2S
Acta Crystallographica Section E (2006) 62, 9 o3693-o3694
a=10.142(2)Å b=9.980(2)Å c=14.428(2)Å
α=90.00° β=100.25(2)° γ=90.00°
Aquabis(2-methylquinolin-8-olato-κ^2^N,O)zinc(II)
C20H18N2O3Zn
Acta Crystallographica Section E (2007) 63, 1 m129-m131
a=7.2840(10)Å b=9.131(2)Å c=25.199(5)Å
α=90.00° β=90.00° γ=90.00°
4,5,6,8,9-Pentachloropyrimido[1,2a][1,8]naphthyridin-10-one
C11H2Cl5N3O
Acta Crystallographica Section C (2005) 61, 1 o1-o3
a=16.453(3)Å b=7.1730(10)Å c=22.368(3)Å
α=90.00° β=107.26(2)° γ=90.00°
<i>N</i>-(4-Methoxybenzyl)-3-[(1E)-3-oxo-3-phenylprop-1-en-1- yl]benzenesulfonamide
C24H23NO5S
Acta Crystallographica Section E (2007) 63, 8 o3437-o3438
a=10.7540(10)Å b=10.9500(10)Å c=11.307(2)Å
α=65.020(2)° β=65.64(2)° γ=85.92(2)°